Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system
- 1 May 2017
- journal article
- case report
- Published by Elsevier in Joint Bone Spine
- Vol. 84 (3) , 353-356
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mycophenolate mofetil in primary central nervous system vasculitisSeminars in Arthritis and Rheumatism, 2015
- Adult Primary Central Nervous System Vasculitis Treatment and Course: Analysis of One Hundred Sixty‐Three PatientsArthritis & Rheumatology, 2015
- Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS diseaseNeurology, 2014
- Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapyRheumatology, 2013
- Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with InfliximabThe Journal of Rheumatology, 2012
- Childhood primary angiitis of the central nervous system: Identifying disease trajectories and early risk factors for persistently higher disease activityArthritis & Rheumatism, 2012
- Treatment of small vessel primary CNS vasculitis in children: an open-label cohort studyThe Lancet Neurology, 2010
- Central nervous system vasculitis in childrenCurrent Opinion in Rheumatology, 2010
- Primary angiitis of the central nervous system: response to mycophenolate mofetilJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Primary angiitis of the central nervous system: diagnostic criteria and clinical approachCleveland Clinic Journal of Medicine, 1992